Literature DB >> 7630429

Mechanisms of the contractile effects of flosequinoxan.

N Zimmermann1, G S Bodor, P Boknik, E Gams, L R Jones, J Neumann, H Scholz.   

Abstract

In guinea-pig papillary muscles the positive inotropic effect of flosequinoxan (BTS) starting at 100 mumol/l amounted to 287.6 +/- 34.2% at 300 mumol/l without any effects on time to peak tension (103.9 +/- 2%) and relaxation time (107.1 +/- 6.7% of predrug value, respectively). 10 mumol/l carbachol attenuated the positive inotropic effect of 300 mumol/l to 166.5 +/- 11.6% (n = 10). The phosphorylation state of the inhibitory subunit of troponin (TnI) and phospholamban (PLB) in [32P]-labeled guinea-pig ventricular myocytes was increased starting at 100 mumol/l amounting to 142.5 +/- 12.6% and 130.9 +/- 2.2% at 300 mumol/l, respectively (n = 5). Furthermore, BTS (300 mumol/l) decreased phosphorylase phosphatase activity by 23.1%. It is concluded that the contractile effects of BTS are accompanied by enhanced phosphorylation of regulatory proteins which could in part be due to inhibition of phosphorylase phosphatase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630429     DOI: 10.1007/bf00169079

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium.

Authors:  M Korth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

2.  The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers.

Authors:  A J Cowley; R D Wynne; J R Hampton
Journal:  J Hypertens Suppl       Date:  1984-12

3.  Autonomic regulation of type 1 protein phosphatase in cardiac muscle.

Authors:  Z Ahmad; F J Green; H S Subuhi; A M Watanabe
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

4.  Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins.

Authors:  S T Rapundalo; R J Solaro; E G Kranias
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

5.  Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.

Authors:  R C Gupta; J Neumann; A M Watanabe
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

6.  Phosphodiesterase-inhibiting properties of newer inotropic agents.

Authors:  H Scholz; W Meyer
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

7.  Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.

Authors:  C L Perreault; N L Hague; E Loh; I M Hunneyball; M F Sim; J P Morgan
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

8.  Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction.

Authors:  G S Bodor; S Porter; Y Landt; J H Ladenson
Journal:  Clin Chem       Date:  1992-11       Impact factor: 8.327

9.  Pharmacokinetics of flosequinan in elderly patients with chronic congestive heart failure.

Authors:  M Sakai; S Ohkawa; T Kaku; K Kuboki; K Chida; T Imai
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.

Authors:  R E Weishaar; A M Wallace; L M Kiser; V A Ferraris; L W Britton; M F Sim
Journal:  J Cardiovasc Pharmacol       Date:  1994-05       Impact factor: 3.105

View more
  2 in total

1.  PACAP induces bradycardia in guinea-pig heart by stimulation of atrial cholinergic neurones.

Authors:  J Seebeck; W E Schmidt; H Kilbinger; J Neumann; N Zimmermann; S Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

2.  Mechanisms of the contractile effects of 2,3-butanedione-monoxime in the mammalian heart.

Authors:  N Zimmermann; P Boknik; E Gams; S Gsell; L R Jones; R Maas; J Neumann; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.